Evidence map›Paper›PMID 32165419›Full record

ArticleJournal of the American Society of Nephrology : JASN2020

Terminally Differentiated Effector Memory CD8

Lola Jacquemont, Gaëlle Tilly, Michelle Yap, Tra-My Doan-Ngoc, Richard Danger, Pierrick Guérif, Florent Delbos, Bernard Martinet, Magali Giral, Yohann Foucher and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exhaustion of CD8Frontiers in immunology · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. TInternational journal of molecular sciences · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lola JacquemontUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Gaëlle TillyUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Michelle YapUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Tra-My Doan-NgocUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Richard DangerUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.ORCID 0000-0002-5058-795X
Pierrick GuérifCHU Nantes, Université de Nantes, ITUN, Nantes, France.
Florent DelbosEtablissement Français du Sang, Nantes, France; and.
Bernard MartinetUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Magali GiralUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Yohann FoucherINSERM, Université de Nantes, methodS in Patient-centered outcomes and HEalth ResEarch (SPHERE), UMR1246, Nantes, France.ORCID 0000-0003-0330-7457
Sophie BrouardUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France.
Nicolas DegauqueUniversité de Nantes, Inserm, Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Nantes, France; nicolas.degauque@univ-nantes.fr.ORCID 0000-0003-2990-3513
Inserm · FRCentre Hospitalier Universitaire de Nantes · FRÉtablissement Français du Sang · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentifying biomarkers to predict kidney transplant failure and to define new therapeutic targets requires more comprehensive understanding of the immune response to chronic allogeneic stimulation.

methodsWe investigated the frequency and function of CD8

resultsIncreased frequency of circulating TEMRA CD8

conclusionsAt 1 year post-transplant, the composition of memory CD8

Indexed as

CD8-Positive T-LymphocytesGraft SurvivalKidney TransplantationAdultAgedBiomarkersCohort StudiesFemaleGraft RejectionHumansImmunologic MemoryKidney Failure, ChronicMaleMiddle AgedPredictive Value of TestsRisk AssessmentBiomarkerschronic allograft rejectionclinical immunologyimmunology and pathologykidney transplantationlymphocytes

Identifiers

PMID32165419
PMCPMC7191929
OpenAlexW3011507190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.